Figure 1.
Potential target organs for the therapeutic options in managing the metabolic aspects of PCOS.
DPP-4, dipeptidyl peptidase-4; GLP-1, glucagon-like peptide-1; PCOS, polycystic ovary syndrome; SGLT2, sodium-glucose cotransporter 2.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.